SureTrader
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

BlackDoggie's partial quote I want to reply on:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ahab333 Member Profile
Member Level 
Followed By 26
Posts 2,843
Boards Moderated 2
Alias Born 04/27/11
160x600 placeholder
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 1/23/2018 8:14:51 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/23/2018 8:03:45 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/23/2018 7:51:29 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 1/10/2018 5:01:36 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/10/2018 4:56:01 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 1/8/2018 4:37:58 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 1/8/2018 4:36:15 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 12/29/2017 5:18:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/29/2017 5:13:14 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 12/21/2017 4:30:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/21/2017 6:06:16 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 12/15/2017 7:37:52 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 12/7/2017 4:58:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/7/2017 4:53:09 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 12/6/2017 5:25:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/6/2017 4:32:06 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) "Edgar (US Regulatory)" - 11/27/2017 4:37:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/27/2017 4:32:49 PM
Tender Offer Statement by Issuer (sc To-i) "Edgar (US Regulatory)" - 11/24/2017 4:28:37 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 11/16/2017 4:12:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2017 4:34:16 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/8/2017 4:34:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/2/2017 4:33:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/13/2017 7:20:39 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/11/2017 7:53:23 AM
ahab333 Member Level  Friday, 11/10/17 03:28:39 PM
Re: BlackDoggie post# 18097
Post # of 19537 
BlackDoggie's partial quote I want to reply on:
_____________________________________________________________________
" Worst reason I could think of - since data could not have been evaluated and we have no notice of severe adverse effects - would be the FDA colluding with BP to delay development "
_____________________________________________________________________

One never knows what big pharma can do when faced with very strong competition with a drug that they have. I am very serious posting this because it is a strong possibility for a big corporation to styme an ongoing new drug like Pro-140. I wouldn't doubt it could be done and wouldn't doubt a government agency to accept, well you all know what I'm trying to say here but I won't. Big eyes could be watching everywhere - GLTU and all longs

HCIT


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist